AYALA PHARMACEUTICALS INC's ticker is AYLA and the CUSIP is 05465V108. A total of 12 filers reported holding AYALA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,001 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 318,599 | $3,613,000 | 1.15% |
| Ikarian Capital, LLC | 538,939 | $6,112,000 | 0.43% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 40,956 | $464,000 | 0.26% |
| Redmile Group, LLC | 667,816 | $7,573,000 | 0.13% |
| BOOTHBAY FUND MANAGEMENT, LLC | 53,784 | $610,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 53,000 | $601,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 961,609 | $10,905,000 | 0.00% |
| Marshall Wace North America L.P. | 49,266 | $559,000 | 0.00% |
| Chevy Chase Trust Holdings, LLC | 15,000 | $170,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 163 | $2,000 | 0.00% |